Sennoside 8.6mg

Manufacturer: Strive Pharmaceuticals Inc.
Effective date: 2020-11-16
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 23:33:43

Label at a glance#

ProductSennoside 8.6mg

Active ingredientSENNOSIDES A AND B

Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Sennoside 8.6mg

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dibasic calcium phosphate, hydroxypropyl methyl cellulose, magnesium stearate, polyethylene glycol

DOSAGE & ADMINISTRATION SECTION

do not take more than directed
take with full glass of water
take preferably at bedtime or as directed by a doctor

Age	Starting dosage	Maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)
generally causes a bowel movement in 6-12 hours

WARNINGS SECTION

Do not use

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

stomach pain
nausea
vomiting
notice a sudden change in bowel habits that continue over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding

ask a health professional before use

Keep out of reach of children

Overdose Warning: In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Incase of accidental overdose, get medical help or contact a Poison Contril Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

OTC - PURPOSE SECTION

Laxative

OTHER SAFETY INFORMATION

Store at room temperature between 20 ^ºC - 25 ^ºC (68 ^ºF - 77 ^ºF).

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CT11241

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
312935	sennosides 8.6 MG Oral Tablet	PSN	1
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	1
312935	sennosides A and B 8.6 MG Oral Tablet	SY	1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70692-112-41	2022-01-28	C162847	48780-1	d6a99b39-ff18-a426-e053-dadaa90af4c2	Laxative - Laxante (Sennoside 8.6mg)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70692-112-41	Sennoside 8.6mg	4 in 1 PACKAGE	TABLET, FILM COATED	4		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70692-112	SENNOSIDE 8.6MG TABLET, FILM COATED [STRIVE PHARMACEUTICALS INC.]	1	Legacy NDC, 1 package rows	20201117_91d0c4ad-7329-6d49-e053-2a95a90a4091.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Sennoside 8.6mg
SENNOSIDES A AND B
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL 400
HYPROMELLOSES

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
70692-112	70692-112-41

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SENNOSIDES A AND B	1B5FPI42EN	ACTIB
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
HYPROMELLOSES	3NXW29V3WO	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
91d05a3f-15e4-f161-e053-2995a90a997c			91d0c4ad-7329-6d49-e053-2a95a90a4091	2020-11-16	Warnings	Exact identifier spl id: 91d05a3f-15e4-f161-e053-2995a90a997c spl set id: 91d0c4ad-7329-6d49-e053-2a95a90a4091

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.